ATAL's Award-Winning AMSFS III Granted Patent in Mainland China
Boasts fast precipitation, high efficiency, small footprint and low investment cost Demonstrates commitment to innovation and sustainable development
HONG KONG, Sep 15, 2022 - (ACN Newswire) - Analogue Holdings Limited (stock code: 1977) together with its subsidiaries (referred to as "ATAL Engineering Group", "ATAL" or the "Group"), a leading electrical and mechanical ("E&M") engineering services provider in Hong Kong, today announced that the China National Intellectual Property Administration ("CNIPA") has granted the Group the utility model patent for its award-winning(1) in-house developed sewage treatment technology "ATAL Multi-Stages Flocculation Sedimentation III" ("AMSFS III"). It further strengthens the Group's extensive portfolio of patents acquired, whilst demonstrating its expertise in and commitment to technological innovation and environmental protection.
| The utility model patent certificate granted by the China National Intellectual Property Administration. |
| ATAL's in-house developed sewage treatment technology "ATAL Multi-Stages Flocculation Sedimentation III" ("AMSFS III") has been applied in sewage projects in Mainland China. |
| ATAL's in-house developed sewage treatment technology "ATAL Multi-Stages Flocculation Sedimentation III" ("AMSFS III") has been applied in sewage projects in Mainland China. |
Dr Otto Poon Lok-To, Chairman of ATAL Engineering Group, said, "We are gratified that CNIPA granted us the utility model patent for AMSFS III technology, recognising our cross-border teams' collaborations and the capability of in-house technological development. Despite the established market for traditional sewage treatment systems, we saw a surging demand for easy-to-install systems in remote villages and rural areas. With our highly flexible containerised AMSFS III system, I believe we are well-positioned to capture business opportunities in Mainland China and other countries included in the Belt and Road Initiative. Going forward, we will continue to pursue technological breakthroughs, aiming to strengthen environmental protection and improve quality of life through continuous innovation."
Co-designed and built by the Group's Hong Kong and Mainland China teams, while manufactured in the Group's factory in Nanjing, AMSFS III is an all-in-one wastewater treatment system leveraging the latest construction technologies including Building Information Modelling ("BIM"), Modular Integrated Construction ("MiC") and Multi-Trade integrated Mechanical, Electrical, and Plumbing ("MiMEP"). In contrast to the conventional system, where all works must be conducted on-site, AMSFS III, with application of the aforementioned technologies, is prefabricated, installed and tested in the factory. Given that it requires small footprint of less than 50m2, AMSFS III provides greater flexibility while reducing the negative impact on the surrounding environment, such as dust and noise pollution at site. The system is containerised and can be installed underground. On the cost and performance front, the fully automatic system has remote monitoring capability to reduce the number of operators needed, which is highly efficient and saves labour and maintenance costs.
AMSFS III has been applied in the Group's sewage projects in Mainland China, making significant contributions to the development of the country's wastewater treatment facilities. In particular, AMSFS III was utilised to remove partial suspended solid and total phosphorus in the Shiwuli River Jinzhai Road Initial Stormwater Reservoir Project located in Hefei city. The system enabled effluent to meet the discharge standard without post-filtration and reduced overall construction costs. The Group also deployed AMSFS III in the upgrade of the wastewater treatment facilities for the area along the Macao River in Anhui province, maintaining the effluent quality to achieve Grade A standard as defined in the "Discharge Standard of Pollutants for Municipal Wastewater Treatment Plants".
Going forward, it is expected that small-scale and decentralised sewage treatment plants ("STPs") will be in high demand in remote villages and rural areas. Given its small footprint, AMSFS III will be a good fit for these areas. With the current Five-Year Plan of the People's Republic of China requiring the National Grade A discharge standard of STPs to be implemented under stringent environmental controls, new opportunities will emerge for small-scale and easy-to-transport sewage treatment systems.
About ATAL Engineering Group Established in 1977, ATAL Engineering Group ("ATAL") is a leading electrical and mechanical ("E&M") engineering service provider headquartered in Hong Kong, with operations in Macau, Mainland China, the United States and the United Kingdom. Serving a wide spectrum of customers from public and private sectors, ATAL provides multi-disciplinary and comprehensive E&M engineering and technology services in four major segments, including Building Services, Environmental Engineering, Information, Communications and Building Technologies ("ICBT") and Lifts & Escalators. ATAL's parent company, Analogue Holdings Limited, is listed on the Main Board of the Stock Exchange of Hong Kong (Stock Code: 1977).
(1) AMSFS III has been awarded the "Innovation and Creativity Award" at "2021-22 Hong Kong Awards for Industries: Innovation and Creativity"
Source: Analogue Holdings Limited Sectors: Engineering
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025 Nov 22, 2024 11:00 JST
| NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth Nov 21, 2024 22:59 JST
| Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan Nov 21, 2024 15:35 JST
| Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP Nov 21, 2024 09:00 JST
| ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study Nov 20, 2024 23:05 JST
| Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center Nov 20, 2024 15:30 JST
| Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Nov 20, 2024 11:51 JST
| Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Nov 20, 2024 10:24 JST
| Kingsoft Announces 2024 Third Quarter Results Nov 19, 2024 18:54 JST
| NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Nov 19, 2024 15:30 JST
| Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings Nov 19, 2024 09:02 JST
| CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report Nov 18, 2024 23:30 JST
| World's First Successful Trial of Quantum Tokens Created Using Quantum Technology Nov 18, 2024 17:29 JST
| Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business Nov 18, 2024 12:31 JST
| Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round Nov 18, 2024 09:25 JST
| COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding Nov 16, 2024 18:00 JST
| Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki Nov 15, 2024 18:58 JST
| Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment) Nov 15, 2024 17:33 JST
| Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Nov 15, 2024 14:31 JST
| Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism Nov 15, 2024 12:32 JST
|
More Latest Release >>
|